Peoples' Friendship University of Russia (RUDN University), Moscow, Russia.
Bull Exp Biol Med. 2021 May;171(2):194-197. doi: 10.1007/s10517-021-05193-5. Epub 2021 Jun 26.
Restenosis remains the main complication after percutaneous coronary interventions in patients with coronary heart disease. The causes of its development include, in particular, genetic factors. We studied polymorphic loci of genes encoding endothelin-1 (EDN1 rs5370), endothelin-1 receptor (EDNRA rs5333), endothelin-converting enzyme (ECE1 rs1076669), and endothelial NO synthase (eNOS rs1549758, eNOS rs1799983, and eNOS rs2070244) in the context of in-stent restenosis development. It was found that the analyzed polymorphisms of the endothelin system genes were more significant for patients aged ≥ 65 years, while the polymorphic loci of the endothelial NO synthase gene (eNOS rs1799983 and eNOS rs1549758) were predominantly associated with time of in-stent restenosis. The obtained results can be useful for comprehensive assessment of the restenosis risk factors and the choice of optimal treatment for patients with coronary heart disease before elective surgical intervention.
支架内再狭窄仍然是冠心病患者经皮冠状动脉介入治疗后的主要并发症。其发展的原因包括遗传因素。我们研究了编码内皮素-1(EDN1 rs5370)、内皮素-1 受体(EDNRA rs5333)、内皮素转换酶(ECE1 rs1076669)和内皮型一氧化氮合酶(eNOS rs1549758、eNOS rs1799983 和 eNOS rs2070244)的基因多态性在支架内再狭窄发展中的作用。结果发现,内皮素系统基因的分析多态性在年龄≥65 岁的患者中更为显著,而内皮型一氧化氮合酶基因(eNOS rs1799983 和 eNOS rs1549758)的多态性位点主要与支架内再狭窄的时间相关。这些结果对于综合评估冠心病患者择期手术干预前的再狭窄危险因素和选择最佳治疗方案可能有用。